Effect of different freezing rates during cryopreservation of rat mesenchymal stem cells using combinations of hydroxyethyl starch and dimethylsulfoxide

BMC Biotechnology

Alexandra Stolzing¹  Viktoriya Fedorova¹  Marek Staude¹  Yahaira Naaldijk¹ 

[1]Fraunhofer Institute for Cell Therapy and Immunology, Perlickstrasse 1, Leipzig, 04103, Germany

关键词: Hydroxyethyl starch;    Controlled rate freezing;    Cryopreservation;    Mesenchymal stem cells;   

Others  :  1134954
DOI  :  10.1186/1472-6750-12-49

 received in 2012-04-10, accepted in 2012-07-31,  发布年份 2012

【 摘 要 】

Background

Mesenchymal stem cells (MSCs) are increasingly used as therapeutic agents as well as research tools in regenerative medicine. Development of technologies which allow storing and banking of MSC with minimal loss of cell viability, differentiation capacity, and function is required for clinical and research applications. Cryopreservation is the most effective way to preserve cells long term, but it involves potentially cytotoxic compounds and processing steps. Here, we investigate the effect of decreasing dimethyl sulfoxide (DMSO) concentrations in cryosolution by substituting with hydroxyethyl starch (HES) of different molecular weights using different freezing rates. Post-thaw viability, phenotype and osteogenic differentiation capacity of MSCs were analysed.

Results

The study confirms that, for rat MSC, cryopreservation effects need to be assessed some time after, rather than immediately after thawing. MSCs cryopreserved with HES maintain their characteristic cell surface marker expression as well as the osteogenic, adipogenic and chondrogenic differentiation potential. HES alone does not provide sufficient cryoprotection for rat MSCs, but provides good cryoprotection in combination with DMSO, permitting the DMSO content to be reduced to 5%. There are indications that such a combination would seem useful not just for the clinical disadvantages of DMSO but also based on a tendency for reduced osteogenic differentiation capacity of rat MSC cryopreserved with high DMSO concentration. HES molecular weight appears to play only a minor role in its capacity to act as a cryopreservation solution for MSC. The use of a ‘straight freeze’ protocol is no less effective in maintaining post-thaw viability of MSC compared to controlled rate freezing methods.

Conclusion

A 5% DMSO / 5% HES solution cryopreservation solution using a ‘straight freeze’ approach can be recommended for rat MSC.

【 授权许可】

   
2012 Naaldjik et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

【 参考文献 】

• [1]Abdallah BM, Kassem M: Human mesenchymal stem cells: from basic biology to clinical applications. Gene Ther 2008, 15:109-116.
• [2]Chamberlain G, Fox J, Ashton B, Middleton J: Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells 2007, 25:2739-2749.
• [3]Reyes M, Verfaillie CM: Characterization of multipotent adult progenitor cells, a subpopulation of mesenchymal stem cells. Ann N Y Acad Sci 2001, 938:231-233. discussion 233–235
• [4]Woodbury D, Schwarz EJ, Prockop DJ, Black IB: Adult rat and human bone marrow stromal cells differentiate into neurons. J Neurosci Res 2000, 61:364-370.
• [5]Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR: Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147.
• [6]Wakitani S, Saito T, Caplan AI: Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine. Muscle Nerve 1995, 18:1417-1426.
• [7]Qi W, Ding D, Salvi RJ: Cytotoxic effects of dimethyl sulphoxide (DMSO) on cochlear organotypic cultures. Hear Res 2008, 236:52-60.
• [8]Wang X, Hua TC, Sun DW, Liu B, Yang G, Cao Y: Cryopreservation of tissue-engineered dermal replacement in Me2SO: Toxicity study and effects of concentration and cooling rates on cell viability. Cryobiology 2007, 55:60-65.
• [9]Katkov II, Kim MS, Bajpai R, Altman YS, Mercola M, Loring JF, Terskikh AV, Snyder EY, Levine F: Cryopreservation by slow cooling with DMSO diminished production of Oct-4 pluripotency marker in human embryonic stem cells. Cryobiology 2006, 53:194-205.
• [10]Reubinoff BE, Pera MF, Vajta G, Trounson AO: Effective cryopreservation of human embryonic stem cells by the open pulled straw vitrification method. Hum Reprod 2001, 16:2187-2194.
• [11]Haack-Sorensen M, Bindslev L, Mortensen S, Friis T, Kastrup J: The influence of freezing and storage on the characteristics and functions of human mesenchymal stromal cells isolated for clinical use. Cytotherapy 2007, 9:328-337.
• [12]Lee RH, Kim B, Choi I, Kim H, Choi HS, Suh K, Bae YC, Jung JS: Characterization and expression analysis of mesenchymal stem cells from human bone marrow and adipose tissue. Cell Physiol Biochem 2004, 14:311-324.
• [13]Hunt CJ: Cryopreservation of Human Stem Cells for Clinical Application: A Review. Transfus Med Hemother 2011, 38:107-123.
• [14]Djuwantono T, Wirakusumah FF, Achmad TH, Sandra F, Halim D, Faried A: A comparison of cryopreservation methods: Slow-cooling vs. rapid-cooling based on cell viability, oxidative stress, apoptosis, and CD34+ enumeration of human umbilical cord blood mononucleated cells. BMC Res Notes 2011, 4:371. BioMed Central Full Text
• [15]Bruder SP, Jaiswal N, Haynesworth SE: Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation. J Cell Biochem 1997, 64:278-294.
• [16]Kotobuki N, Hirose M, Machida H, Katou Y, Muraki K, Takakura Y, Ohgushi H: Viability and osteogenic potential of cryopreserved human bone marrow-derived mesenchymal cells. Tissue Eng 2005, 11:663-673.
• [17]Perry BC, Zhou D, Wu X, Yang FC, Byers MA, Chu TM, Hockema JJ, Woods EJ, Goebel WS: Collection, cryopreservation, and characterization of human dental pulp-derived mesenchymal stem cells for banking and clinical use. Tissue Eng Part C Methods 2008, 14:149-156.
• [18]Rust PA, Costas C, Cannon SR, Briggs TW, Blunn GW: Characterisation of cryopreserved cells freshly isolated from human bone marrow. Cryo Letters 2006, 27:17-28.
• [19]Liu G, Zhou H, Li Y, Li G, Cui L, Liu W, Cao Y: Evaluation of the viability and osteogenic differentiation of cryopreserved human adipose-derived stem cells. Cryobiology 2008, 57:18-24.
• [20]Bhakta G, Lee KH, Magalhaes R, Wen F, Gouk SS, Hutmacher DW, Kuleshova LL: Cryopreservation of alginate-fibrin beads involving bone marrow derived mesenchymal stromal cells by vitrification. Biomaterials 2009, 30:336-343.
• [21]Moon JH, Kwak SS, Park G, Jung HY, Yoon BS, Park J, Ryu KS, Choi SC, Maeng I, Kim B, et al.: Isolation and characterization of multipotent human keloid-derived mesenchymal-like stem cells. Stem Cells Dev 2008, 17:713-724.
• [22]Goh BC, Thirumala S, Kilroy G, Devireddy RV, Gimble JM: Cryopreservation characteristics of adipose-derived stem cells: maintenance of differentiation potential and viability. J Tissue Eng Regen Med 2007, 1(4):322-324.
• [23]Lee MW, Choi J, Yang MS, Moon YJ, Park JS, Kim HC, Kim YJ: Mesenchymal stem cells from cryopreserved human umbilical cord blood. Biochem Biophys Res Commun 2004, 320:273-278.
• [24]Higman MA, Port JD, Beauchamp NJ, Chen AR: Reversible leukoencephalopathy associated with re-infusion of DMSO preserved stem cells. Bone Marrow Transplant 2000, 26:797-800.
• [25]Hequet O, Dumontet C, El Jaafari-Corbin A, Salles G, Espinouse D, Arnaud P, Thieblemont C, Bouafia F, Coiffier B: Epileptic seizures after autologous peripheral blood progenitor infusion in a patient treated with high-dose chemotherapy for myeloma. Bone Marrow Transplant 2002, 29:544.
• [26]Gomez S, Nagler A, Naparstek E, Slavin S: Transient elevation of serum lactic dehydrogenase following autologous bone marrow transplantation. Bone Marrow Transplant 1991, 7:487-488.
• [27]Penninckx F, Cheng N, Kerremans R, Van Damme B, De Loecker W: The effects of different concentrations of glycerol and dimethylsulfoxide on the metabolic activities of kidney slices. Cryobiology 1983, 20:51-60.
• [28]Thirumala S, Gimble JM, Devireddy RV: Evaluation of methylcellulose and dimethyl sulfoxide as the cryoprotectants in a serum-free freezing media for cryopreservation of adipose-derived adult stem cells. Stem Cells Dev 2010, 19:513-522.
• [29]Thirumala S, Gimble JM, Devireddy RV: Cryopreservation of stromal vascular fraction of adipose tissue in a serum-free freezing medium. J Tissue Eng Regen Med 2010, 4:224-232.
• [30]Liu Y, Xu X, Ma XH, Liu J, Cui ZF: Effect of various freezing solutions on cryopreservation of mesenchymal stem cells from different animal species. Cryo Letters 2011, 32:425-435.
• [31]Allen ED, Weatherbee L, Spencer HH, Lindenauer SM, Permoad PA: Large unit red cell cryopreservation with hydroxyethyl starch. Cryobiology 1976, 13:500-506.
• [32]Pasch J, Schiefer A, Heschel I, Dimoudis N, Rau G: Variation of the HES concentration for the cryopreservation of keratinocytes in suspensions and in monolayers. Cryobiology 2000, 41:89-96.
• [33]Sudo K, Asoh S, Ohsawa I, Ozaki D, Yamagata K, Ito H, Ohta S: The anti-cell death FNK protein protects cells from death induced by freezing and thawing. Biochem Biophys Res Commun 2005, 330:850-856.
• [34]Celluzzi CM, Welbon C: A simple cryopreservation method for dendritic cells and cells used in their derivation and functional assessment. Transfusion 2003, 43:488-494.
• [35]Ashwood-Smith MJ, Warby C, Connor KW, Becker G: Low-temperature preservation of mammalian cells in tissue culture with polyvinylpyrrolidone (PVP), dextrans, and hydroxyethyl starch (HES). Cryobiology 1972, 9:441-449.
• [36]Sputtek A, Jetter S, Hummel K, Kuhnl P: Cryopreservation of peripheral blood progenitor cells: characteristics of suitable techniques. Beitr Infusionsther Transfusionsmed 1997, 34:79-83.
• [37]Horn EP, Sputtek A, Standl T, Rudolf B, Kuhnl P, Schulte am Esch J: Transfusion of autologous, hydroxyethyl starch-cryopreserved red blood cells. Anesth Analg 1997, 85:739-745.
• [38]Lionetti FJ, Hunt SM: Cryopreservation of human red cells in liquid nitrogen with hydroxyethyl starch. Cryobiology 1975, 12:110-118.
• [39]Persidsky MD, Ellett MH: Hydroxyethyl starch as a cryopreservative for nucleated mammalian cells. Cryobiology 1971, 8:586-588.
• [40]Stiff PJ, Koester AR, Weidner MK, Dvorak K, Fisher RI: Autologous bone marrow transplantation using unfractionated cells cryopreserved in dimethylsulfoxide and hydroxyethyl starch without controlled-rate freezing. Blood 1987, 70:974-978.
• [41]Boldt J: Modern rapidly degradable hydroxyethyl starches: current concepts. Anesth Analg 2009, 108:1574-1582.
• [42]Westphal M, Lamszus K: Other experimental therapies for glioma. Recent Results Cancer Res 2009, 171:155-164.
• [43]Stolzing A, Naaldijk Y, Fedorova V, Sethe S: Hydroxyethylstarch in cryopreservation - Mechanisms, benefits and problems. Transfus Apher Sci 2012, 46:137-147.
• [44]Rodrigues JP, Paraguassu-Braga FH, Carvalho L, Abdelhay E, Bouzas LF, Porto LC: Evaluation of trehalose and sucrose as cryoprotectants for hematopoietic stem cells of umbilical cord blood. Cryobiology 2008, 56:144-151.
• [45]Rowley SD, Feng Z, Chen L, Holmberg L, Heimfeld S, MacLeod B, Bensinger WI: A randomized phase III clinical trial of autologous blood stem cell transplantation comparing cryopreservation using dimethylsulfoxide vs dimethylsulfoxide with hydroxyethylstarch. Bone Marrow Transplant 2003, 31:1043-1051.
• [46]Pasch J, Schiefer A, Heschel I, Rau G: Cryopreservation of keratinocytes in a monolayer. Cryobiology 1999, 39:158-168.
• [47]Teasdale B, Sieber VK, Riches DJ, Nanchahal J: Cryopreservation of cultured dermal fibroblast impregnated collagen gels. Burns 1993, 19:406-410.
• [48]Kearney JN: Cryopreservation of cultured skin cells. Burns 1991, 17:380-383.
• [49]Ji L, de Pablo JJ, Palecek SP: Cryopreservation of adherent human embryonic stem cells. Biotechnol Bioeng 2004, 88:299-312.
• [50]Stiff PJ, Murgo AJ, Zaroulis CG, DeRisi MF, Clarkson BD: Unfractionated human marrow cell cryopreservation using dimethylsulfoxide and hydroxyethyl starch. Cryobiology 1983, 20:17-24.
• [51]Rowley SD, Anderson GL: Effect of DMSO exposure without cryopreservation on hematopoietic progenitor cells. Bone Marrow Transplant 1993, 11:389-393.
• [52]Leibo SP, Mazur P: The role of cooling rates in low-temperature preservation. Cryobiology 1971, 8:447-452.
• [53]Franks F, Mathias SF, Galfre P, Webster SD, Brown D: Ice nucleation and freezing in undercooled cells. Cryobiology 1983, 20:298-309.
• [54]Mazur P: Freezing of living cells: mechanisms and implications. Am J Physiol 1984, 247:C125-C142.
• [55]Kandra D, Devireddy RV: Numerical Simulation of Local Temperature Distortions During Ice Nucleation of Cells in Suspension. Int J Heat Mass Transf 2008, 51:5655-5661.
• [56]Martinello T, Bronzini I, Maccatrozzo L, Mollo A, Sampaolesi M, Mascarello F, Decaminada M, Patruno M: Canine adipose-derived-mesenchymal stem cells do not lose stem features after a long-term cryopreservation. Res Vet Sci 2011, 91:18-24.
• [57]Martinello T, Bronzini I, Maccatrozzo L, Iacopetti I, Sampaolesi M, Mascarello F, Patruno M: Cryopreservation does not affect the stem characteristics of multipotent cells isolated from equine peripheral blood. Tissue Eng Part C Methods 2010, 16:771-781.
• [58]Heng BC, Ye CP, Liu H, Toh WS, Rufaihah AJ, Yang Z, Bay BH, Ge Z, Ouyang HW, Lee EH, et al.: Loss of viability during freeze-thaw of intact and adherent human embryonic stem cells with conventional slow-cooling protocols is predominantly due to apoptosis rather than cellular necrosis. J Biomed Sci 2006, 13:433-445.
• [59]Heng BC: Effect of Rho-associated kinase (ROCK) inhibitor Y-27632 on the post-thaw viability of cryopreserved human bone marrow-derived mesenchymal stem cells. Tissue Cell 2009, 41:376-380.
• [60]Carvalho KA, Cury CC, Oliveira L, Cattaned RI, Malvezzi M, Francisco JC, Pachalok A, Olandoski M, Faria-Neto JR, Guarita-Souza LC: Evaluation of bone marrow mesenchymal stem cell standard cryopreservation procedure efficiency. Transplant Proc 2008, 40:839-841.
• [61]Ock SA, Rho GJ: Effect of dimethyl sulfoxide (DMSO) on cryopreservation of porcine mesenchymal stem cells (pMSCs). Cell Transplant 2011, 20:1231-1239.
• [62]Li H, Yan F, Lei L, Li Y, Xiao Y: Application of autologous cryopreserved bone marrow mesenchymal stem cells for periodontal regeneration in dogs. Cells Tissues Organs 2009, 190:94-101.
• [63]Borderie VM, Lopez M, Lombet A, Carvajal-Gonzalez S, Cywiner C, Laroche L: Cryopreservation and culture of human corneal keratocytes. Invest Ophthalmol Vis Sci 1998, 39:1511-1519.
• [64]Baust JM, Van B, Baust JG: Cell viability improves following inhibition of cryopreservation-induced apoptosis. In Vitro Cell Dev Biol Anim 2000, 36:262-270.
• [65]Baust JM: Molecular Mechanism of Cellular Demise Associated with Cryopreservation Failure. Cell Preservation Technology 2002, 1:17-31.
• [66]Baust JMV MJ, Snyder KK, Van Buskirk RG, Baust JG: Activation of Mitochondrial-Associated Apoptosis Contributes to Cryopreservation Failure. Cell Preservation Technology 2007, 5:155-164.
• [67]Hronik-Tupaj M, Rice WL, Cronin-Golomb M, Kaplan DL, Georgakoudi I: Osteoblastic differentiation and stress response of human mesenchymal stem cells exposed to alternating current electric fields. Biomed Eng Online 2011, 10:9. BioMed Central Full Text
• [68]Han DW, Kim HH, Lee MH, Baek HS, Lee KY, Hyon SH, Park JC: Protection of osteoblastic cells from freeze/thaw cycle-induced oxidative stress by green tea polyphenol. Biotechnol Lett 2005, 27:655-660.
• [69]Luo K, Wu G, Wang Q, Sun Y, Liu H: Effect of dimethylsulfoxide and hydroxyethyl starch in the preservation of fractionated human marrow cells. Cryobiology 1994, 31:349-354.